Brief Review: Rivastigmine, A Second Cholinesterase Inhibitor

Brief review: rivastigmine, a second cholinesterase inhibitor.

Cholinesterase-inhibitor Associated Mania: A Case Report and Literature Review.

Neuropsychiatric symptoms (NPS) are common in the middle to late stages of Alzheimer’s dementia (AD), but can also present in the Mild Cognitive Impairment (MCI) phase. Since the pathophysiology of AD involves deficits in central cholinergic neurotransmission, cholinesterase inhibitors (CHEIs) are effective in treating its cognitive symptoms. Interestingly, case studies have reported the onset ...

A Pharmacoeconomic Review of Cholinesterase Inhibitor Drugs for Alzheimer’s Disease

S: Turongkaravee S. Cost utility analysis of cholinesterase inhibitors in the treatment of mild to moderate Alzheimer’s disease. Value in Health 2010;13(7):A502. Permsuwan U, Niwatananun W, Pimkrai A. Cost-utility analysis of donepezil for the treatment of Alzheimer’s disease in Thailand. Value in Health 2012;15:A648.

P158: Epilepsy and Anxiety: A Brief Review

Epilepsy is a brain disorder that causes people to have recurring seizures. The seizures happen when clusters of nerve cells, or neurons, in the brain send out the wrong signals. Up to 50 or 60% of patients with chronic epilepsy have various mood disorders including depression and anxiety. Although the affective and cognitive effects of epilepsy have long received attention, the anxiety spectru...

VMI-type Supply Chains: a Brief Review

The primary purpose of this paper is to highlight for the research community and practitioners the various aspects of using VMI-type supply chains in today’s business environment as well as a number of directions for future studies. In this regard, fifty articles published in major international journals, beginning in 1995, which contribute to the VMI-type supply chains are reviewed via a syste...